HUP9901991A2 - Transzdermális eszköz flurbiprofén átadására - Google Patents

Transzdermális eszköz flurbiprofén átadására

Info

Publication number
HUP9901991A2
HUP9901991A2 HU9901991A HUP9901991A HUP9901991A2 HU P9901991 A2 HUP9901991 A2 HU P9901991A2 HU 9901991 A HU9901991 A HU 9901991A HU P9901991 A HUP9901991 A HU P9901991A HU P9901991 A2 HUP9901991 A2 HU P9901991A2
Authority
HU
Hungary
Prior art keywords
polymer
flurbiprofen
delivery
transdermal device
transdermal
Prior art date
Application number
HU9901991A
Other languages
English (en)
Inventor
Jochem J. Effing
Kristin J. Godbey
Eberhard A. Gruhlke
Wolfgang Welsing
Original Assignee
Minnesota Mining And Manufacturing Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining And Manufacturing Co. filed Critical Minnesota Mining And Manufacturing Co.
Publication of HUP9901991A2 publication Critical patent/HUP9901991A2/hu
Publication of HUP9901991A3 publication Critical patent/HUP9901991A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

A találmány transzdermális hatóanyag-átadó eszközökre vőnatkőzik. Atalálmány szerinti transzdermális, hatóanyagőt átadó eszköz magábanfőglal egy akrilát- vagy metakrilátalapú kőpőlimert, egybőrpenetráció-főkőzót, egy pőlivinil-pirrőlidőn pőlimert és terápiásanhatékőny mennyiségű flűrbi-prőfént. ŕ
HU9901991A 1995-12-22 1996-12-16 Transdermal device for the delivery of flurbiprofen HUP9901991A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/577,482 US5702720A (en) 1995-12-22 1995-12-22 Transdermal device for the delivery of flurbiprofen

Publications (2)

Publication Number Publication Date
HUP9901991A2 true HUP9901991A2 (hu) 1999-10-28
HUP9901991A3 HUP9901991A3 (en) 2001-04-28

Family

ID=24308917

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901991A HUP9901991A3 (en) 1995-12-22 1996-12-16 Transdermal device for the delivery of flurbiprofen

Country Status (22)

Country Link
US (2) US5702720A (hu)
EP (2) EP0869781B1 (hu)
JP (2) JP2000503638A (hu)
KR (2) KR19990076588A (hu)
CN (2) CN1098071C (hu)
AR (1) AR005163A1 (hu)
AT (2) ATE241350T1 (hu)
AU (2) AU701782B2 (hu)
CA (2) CA2238400A1 (hu)
CO (1) CO4810224A1 (hu)
CZ (2) CZ197298A3 (hu)
DE (2) DE69628448T2 (hu)
HR (1) HRP960608B1 (hu)
HU (1) HUP9901991A3 (hu)
IL (2) IL124629A (hu)
MX (2) MX9804871A (hu)
MY (1) MY113685A (hu)
NO (2) NO982613L (hu)
NZ (2) NZ325659A (hu)
TW (1) TW436298B (hu)
WO (2) WO1997023205A1 (hu)
ZA (1) ZA9610729B (hu)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
JP3782834B2 (ja) * 1994-10-26 2006-06-07 株式会社トクホン 鎮痛抗炎症貼付剤
DE19830649C2 (de) 1998-07-09 2003-04-10 Lohmann Therapie Syst Lts Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe
DE19834496B4 (de) 1998-07-31 2004-02-26 Beiersdorf Ag Verbesserte Freisetzung von Ibuprofen aus Heißschmelzklebemassen in wirkstoffhaltigen Pflastern durch Zusatz von pharmazeutischen Hilfsstoffen und Verwendung von Hilfsstoffen zur Verbesserung der Freisetzung von Ibuprofen
DE19840191A1 (de) * 1998-09-03 2000-03-09 Lohmann Therapie Syst Lts Arzneistoffhaltiges Pflaster mit drei funktionalen Schichten
US7052714B1 (en) * 1999-10-13 2006-05-30 Senju Pharmaceutical Co., Ltd Ophthalmic adhesive preparations for percutaneous adsorption
US20020110585A1 (en) 1999-11-30 2002-08-15 Godbey Kristin J. Patch therapeutic agent delivery device having texturized backing
US6455067B1 (en) * 2000-05-24 2002-09-24 Sang-A Pharmaceutical Co., Ltd. Transdermal patch for nonsteroidal antiinflammatory drug(s)
DE10032537A1 (de) * 2000-07-05 2002-01-31 Labtec Gmbh Dermales System, enthaltend 2-(3-Benzophenyl)Propionsäure
DE10049225A1 (de) * 2000-09-28 2002-04-11 Labtec Gmbh Dermales System, enthaltend Diclofenac
AU2002235155A1 (en) * 2000-12-05 2002-06-18 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems
US7803392B2 (en) * 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
US6479076B2 (en) * 2001-01-12 2002-11-12 Izhak Blank Nicotine delivery compositions
CN100391462C (zh) * 2001-06-18 2008-06-04 诺芬药品公司 增强的透皮给药系统
US6805878B2 (en) * 2001-09-13 2004-10-19 Noven Pharmaceuticals, Inc. Transdermal administration of ACE inhibitors
US6951642B2 (en) * 2001-09-28 2005-10-04 3M Innovative Properties Company Water-in-oil emulsions with anionic groups, compositions, and methods
US7030203B2 (en) * 2001-09-28 2006-04-18 3M Innovative Properties Company Water-in-oil emulsions with ethylene oxide groups, compositions, and methods
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
US20030152612A1 (en) * 2002-01-03 2003-08-14 Pugliese Peter T. Method and article to control cellulite
US6838078B2 (en) 2002-01-16 2005-01-04 3M Innovative Properties Company Film-forming compositions and methods
US7147873B2 (en) 2002-01-16 2006-12-12 3M Innovative Properties Company Antiseptic compositions and methods
DE10212864B4 (de) * 2002-03-22 2005-12-22 Beiersdorf Ag Polymermatrizes umfassend ein Mischsystem zur Löslichkeitsvermittlung von pharmazeutischen Wirkstoffen, Verfahren zu deren Herstellung und deren Verwendung
KR100517101B1 (ko) * 2002-07-31 2005-09-27 한국과학기술연구원 이중 자극 응답성 하이드로젤 및 이의 제조 방법
US20040062794A1 (en) * 2002-09-30 2004-04-01 Lee Shulman 17Beta- estradiol/levonorgestrel transdermal patch for hormone replacement therapy
EP1602366A4 (en) * 2003-03-10 2013-01-09 Tokuyama Corp TRANSDERMAL STAMP FOR THE ADMINISTRATION OF IONIC DRUGS
AU2004249295A1 (en) * 2003-06-20 2004-12-29 Viral Genomix, Inc. Compositions for and methods for treating HIV
US20050065062A1 (en) * 2003-09-24 2005-03-24 3M Innovative Properties Company Method of formulating a pharmaceutical composition
GB2429651C (en) * 2004-02-17 2009-03-25 Cook Biotech Inc Medical devices and methods useful for applying bolster material
MX2007004315A (es) 2004-10-08 2008-03-11 Noven Pharma Dispositivo para suministro transdermico de farmaco que incluye un respaldo oclusivo.
AU2004324693B2 (en) * 2004-11-05 2011-05-26 Lead Chemical Co., Ltd. Nonaqueous preparation for percutaneous absorption containing nonsteroidal anti-inflammatory analgesic
KR100663163B1 (ko) * 2005-10-24 2007-01-02 (주)아모레퍼시픽 비스테로이드성 소염진통제를 함유하는 경피 투여 제제
EP2046307A2 (en) * 2006-06-14 2009-04-15 Arrow Coated Products Limited Device for delivering active ingredients to humans, animals and plants
KR20080006960A (ko) * 2006-07-14 2008-01-17 (주)아모레퍼시픽 소수성 비스테로이드성 소염진통제를 함유하는 경피 투여제제
US20080039415A1 (en) * 2006-08-11 2008-02-14 Gregory Robert Stewart Retrograde transport of sirna and therapeutic uses to treat neurologic disorders
JP5214223B2 (ja) * 2007-11-15 2013-06-19 船井電機株式会社 プロジェクタ
KR20100113075A (ko) * 2008-05-21 2010-10-20 테이코쿠 팔마 유에스에이, 인코포레이티드 비스테로이드성 항염증제의 경피 투여를 통한 생리통의 치료 방법
WO2010077096A2 (ko) * 2008-12-31 2010-07-08 한올바이오파마주식회사 약물전달기구
US20100291182A1 (en) * 2009-01-21 2010-11-18 Arsenal Medical, Inc. Drug-Loaded Fibers
US8850719B2 (en) 2009-02-06 2014-10-07 Nike, Inc. Layered thermoplastic non-woven textile elements
US8906275B2 (en) 2012-05-29 2014-12-09 Nike, Inc. Textured elements incorporating non-woven textile materials and methods for manufacturing the textured elements
US20100199406A1 (en) 2009-02-06 2010-08-12 Nike, Inc. Thermoplastic Non-Woven Textile Elements
US20100199520A1 (en) * 2009-02-06 2010-08-12 Nike, Inc. Textured Thermoplastic Non-Woven Elements
US9682512B2 (en) 2009-02-06 2017-06-20 Nike, Inc. Methods of joining textiles and other elements incorporating a thermoplastic polymer material
CN101502499B (zh) * 2009-03-13 2011-07-27 北京化工大学 一种布洛芬经皮释放贴剂及其制备方法
US20110202016A1 (en) * 2009-08-24 2011-08-18 Arsenal Medical, Inc. Systems and methods relating to polymer foams
US10420862B2 (en) 2009-08-24 2019-09-24 Aresenal AAA, LLC. In-situ forming foams for treatment of aneurysms
US9044580B2 (en) 2009-08-24 2015-06-02 Arsenal Medical, Inc. In-situ forming foams with outer layer
US9173817B2 (en) 2009-08-24 2015-11-03 Arsenal Medical, Inc. In situ forming hemostatic foam implants
JP5946769B2 (ja) 2009-11-23 2016-07-06 アイエスピー インヴェストメンツ インコーポレイテッドＩｓｐ Ｉｎｖｅｓｔｍｅｎｔｓ Ｉｎｃ． 重合可能反応性官能基を含む重合可能ポリマーの反応性溶液、その方法および組成物
US8968626B2 (en) 2011-01-31 2015-03-03 Arsenal Medical, Inc. Electrospinning process for manufacture of multi-layered structures
US9194058B2 (en) 2011-01-31 2015-11-24 Arsenal Medical, Inc. Electrospinning process for manufacture of multi-layered structures
US9034240B2 (en) 2011-01-31 2015-05-19 Arsenal Medical, Inc. Electrospinning process for fiber manufacture
US8993831B2 (en) 2011-11-01 2015-03-31 Arsenal Medical, Inc. Foam and delivery system for treatment of postpartum hemorrhage
US20130255103A1 (en) 2012-04-03 2013-10-03 Nike, Inc. Apparel And Other Products Incorporating A Thermoplastic Polymer Material
ITMI20121428A1 (it) * 2012-08-10 2014-02-11 Allergosystem S R L Dispositivo per applicazione topica di medicamenti o cosmetici
US20170007703A1 (en) * 2014-01-29 2017-01-12 Nitto Denko Corporation Composition for accelerating penetration through skin, preparation for transdermal administration, and skin patch preparation
DK3139979T3 (da) 2014-05-07 2023-10-09 Boehringer Ingelheim Int Enhed, forstøver og fremgangsmåde
WO2018124089A1 (ja) 2016-12-28 2018-07-05 久光製薬株式会社 貼付剤
US11872320B2 (en) 2021-02-25 2024-01-16 Hisamitsu Pharmaceutical Co., Inc. Method for treating osteoarthritis

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US24906A (en) * 1859-07-26 Simeon goodfellow
IT610737A (hu) * 1955-11-18 1900-01-01
US3949128A (en) * 1972-08-22 1976-04-06 Kimberly-Clark Corporation Product and process for producing a stretchable nonwoven material from a spot bonded continuous filament web
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
JPS55139313A (en) * 1979-04-16 1980-10-31 Ota Seiyaku Kk Gel cream composition comprising higher fatty acid ethanol amide, and drug containing it
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
US5445604A (en) * 1980-05-22 1995-08-29 Smith & Nephew Associated Companies, Ltd. Wound dressing with conformable elastomeric wound contact layer
JPS5855411A (ja) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
US4477468A (en) * 1982-12-06 1984-10-16 The Upjohn Company Treatment of type II herpes virus with flurbiprofen
US4701470A (en) * 1982-12-06 1987-10-20 The Upjohn Company Treatment of Type II Herpes virus with ibuprofen
US4473584A (en) * 1982-12-06 1984-09-25 The Upjohn Company Treatment of Type I Herpes virus with flurbiprofen
JPS59222409A (ja) * 1983-06-01 1984-12-14 Nippon Redarii Kk 消炎鎮痛ゲル軟膏剤
CH662944A5 (it) * 1984-10-18 1987-11-13 Pier Luigi Prof Dr Luisi Procedimento per la preparazione di biocompatibili di micelle inverse di biocompatibili e loro utilizzazione.
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
DE3522550A1 (de) * 1985-06-24 1987-01-02 Klinge Co Chem Pharm Fab Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
GB8701392D0 (en) * 1987-01-22 1987-02-25 Boots Co Plc Therapeutic agents
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
GB2217595B (en) * 1988-04-21 1991-11-20 American Cyanamid Co Antiinflammatory gel
US5230701A (en) * 1988-05-13 1993-07-27 Minnesota Mining And Manufacturing Company Elastomeric adhesive and cohesive materials
US5266723A (en) * 1989-05-16 1993-11-30 Medice, Ltd., Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg Process for the preparation of optically active 2-aryl-alkanoic acids, especially 2-aryl-propionic acids
WO1991006295A1 (en) * 1989-11-06 1991-05-16 Sepracor, Inc. Analgesic composition containing optically pure s(+) flurbiprofen
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
WO1991017740A1 (en) * 1990-05-18 1991-11-28 Analgesic Associates Prevention or treatment of sunburn using the s(+) isomer of flurbiprofen
DE4028906A1 (de) * 1990-09-12 1992-03-19 Paz Arzneimittelentwicklung Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen
TW218849B (hu) * 1991-05-17 1994-01-11 Bristol Myers Squibb Co
US5478567A (en) * 1991-08-30 1995-12-26 Hisamitsu Pharmaceutical Co., Inc. Antiphlogistic analgesic plaster
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
EP0695179A1 (en) * 1993-04-22 1996-02-07 Minnesota Mining And Manufacturing Company Transdermal antiinflammatory composition

Also Published As

Publication number Publication date
MX9804969A (es) 1998-09-30
CN1098069C (zh) 2003-01-08
AU1422097A (en) 1997-07-17
MY113685A (en) 2002-04-30
CN1205631A (zh) 1999-01-20
NZ325659A (en) 2000-02-28
JP2000502349A (ja) 2000-02-29
KR19990076589A (ko) 1999-10-15
CA2240349A1 (en) 1997-07-03
CA2238400A1 (en) 1997-07-03
AU714798B2 (en) 2000-01-13
NZ325125A (en) 2000-05-26
EP0869781B1 (en) 2003-05-28
CN1098071C (zh) 2003-01-08
WO1997023206A1 (en) 1997-07-03
KR100452001B1 (ko) 2004-12-30
CN1205630A (zh) 1999-01-20
CZ197198A3 (cs) 1998-11-11
EP0868177B1 (en) 2003-06-18
MX9804871A (es) 1998-10-31
EP0868177A1 (en) 1998-10-07
JP2000503638A (ja) 2000-03-28
ATE243031T1 (de) 2003-07-15
EP0869781A1 (en) 1998-10-14
WO1997023205A1 (en) 1997-07-03
CZ197298A3 (cs) 1999-01-13
NO982764L (no) 1998-06-15
IL124804A (en) 2001-12-23
ATE241350T1 (de) 2003-06-15
NO982613L (no) 1998-08-21
DE69628762D1 (de) 2003-07-24
NO982613D0 (no) 1998-06-05
KR19990076588A (ko) 1999-10-15
ZA9610729B (en) 1998-06-19
AU701782B2 (en) 1999-02-04
HUP9901991A3 (en) 2001-04-28
DE69628448T2 (de) 2004-04-08
US5702720A (en) 1997-12-30
CO4810224A1 (es) 1999-06-30
IL124629A0 (en) 1998-12-06
IL124804A0 (en) 1999-01-26
DE69628762T2 (de) 2004-04-29
HRP960608B1 (en) 2001-12-31
IL124629A (en) 2001-10-31
NO982764D0 (no) 1998-06-15
TW436298B (en) 2001-05-28
AU1295097A (en) 1997-07-17
DE69628448D1 (de) 2003-07-03
US6086911A (en) 2000-07-11
AR005163A1 (es) 1999-04-14
HRP960608A2 (en) 1997-10-31

Similar Documents

Publication Publication Date Title
HUP9901991A2 (hu) Transzdermális eszköz flurbiprofén átadására
ES2171672T3 (es) Composiciones activadoras de penetracion en la piel mediante la utilizacion de lactilatos de acilo.
IT1285387B1 (it) Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
NO2017011I1 (no) Buprenorfin
DE69426988T2 (de) Transdermale abgabe vorrichtung
ITTO960469A0 (it) Dispositivo per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
HUP0101512A2 (hu) Adhéziós mikrogyöngy hatóanyag-adagoló készítmény, eljárás az előállítására és a készítményt tartalmazó eszköz
ES2137261T3 (es) Administracion transdermica de oxibutinina.
DE69807634D1 (de) Medizinische einrichtung zur verabreichung von therapeutischen wirkstoffen
HUP0001748A2 (hu) Transzdermális eszköz tesztoszteron felszabadítására
ATE244003T1 (de) Transdermales therapeutisches system
NO20004935D0 (no) Anordning til den transdermale avleveringen av diklofenak
HUP0102728A2 (hu) Módszerek és transzdermális készítmények fájdalom csillapítására
NO950725D0 (no) Trykket transdermal medikamentavleveringsinnretning
IT1285398B1 (it) Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
ATE208200T1 (de) Transdermales therapeutisches system (tts) zur verabreichung von testosteron
DE59910944D1 (de) Transdermales therapeutisches system zur anwendung von candesartan
HUP9904181A2 (hu) Felületstabilizált gyógyszerészeti készítmény bőrön való alkalmazáshoz
DK1083900T3 (da) Anvendelse af oxazolidinoner til fremstilling af et medikament til transdermal tilførsel
DK0667774T3 (da) Transdermalt, terapeutisk system til indgivelse af physostigmin genem huden og fremgangsmåde til dets fremstilling
HUP9600147A1 (hu) Molsidomint vagy metabolitját tartalmazó transzdermális gyógyszerforma és eljárás annak előállítására
DE29501910U1 (de) Transdermales therapeutisches den Wirkstoff Dimethisoquin enthaltendes System
NO991047L (no) Transdermal terapeutisk tilnµrming involverende en kombinasjon av aktive substanser inneholdende °striol
NO981020D0 (no) Transdermalt terapautisk system for silatranforbindelser
DK0859595T3 (da) Terapeutisk præparat til transdermal indgivelse af aktive sfoffer gennem huden